- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 25, 2025 | 105.82M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $136.39M |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $161.31M |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $12.27M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $12.23M |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $608.76M |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $604.3M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $417.18M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $396.31M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $616.17M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $616.38M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $633.36M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $623.39M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $1.24B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $1.24B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 103.56M sh |
| Capex | Q1 2025 · Mar 31, 2024 | $2.52M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$26.32M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2024 | $130.18M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2023 | $178.56M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.12 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $80.22M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $16.64M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$11.57M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$10.22M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $86.64M |
| Cost Of Revenue | Q1 2025 · Mar 31, 2024 | $250.62M |
| Revenue | Q1 2025 · Mar 31, 2024 | $337.26M |